Ranking Profile - Cleveland BioLabs Inc

Introduction

Statera Biopharma Inc (Statera Biopharma) is a bio-pharmaceutical company. The company develops and commercializes drugs to treat cancer, orphan indications and protect healthy tissues from radiation and chemotherapy. It product includes entolimod, a recombinant protein that acts as an agonist of toll-like receptor that finds application in radiation mitigation, oncology immunotherapy, and vaccines. Statera Biopharma provides entolimod-oncology, CBLB612, SA-702 – vaccine adjuvant, mobilan, and CBL0137. The company clinical-stage drug candidates are used for the treatment of cancer and protection from lethal radiation. It's products includes to develop using protectan technology and curaxin technology. The company operates in the US and Russia. Statera Biopharma is headquartered in Buffalo, New York, the US.